Pee power: urine bacteria may predict melanoma treatment success
NCT ID NCT07635732
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the bacteria naturally found in urine can help doctors better understand melanoma, a serious skin cancer, and predict how well patients will respond to treatment. Researchers will collect urine and stool samples from 50 people with advanced melanoma starting therapy, plus samples from healthy volunteers for comparison. The study does not change any medical treatment—it simply analyzes samples and questionnaires to find bacterial patterns linked to better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA STAGE IV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Dermatology and Venereology, Medical University of Graz
RECRUITINGGratwein, Styria, 8036, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?
- Experimental virus therapy takes on advanced cancers in first human trial
- New pill aims to boost immune attack on Hard-to-Treat cancers
- New MRI dye could spot brain tumors sooner in cancer patients
- Bone drug may supercharge immunotherapy against tough melanoma
- Last-resort melanoma combo shows early promise in small trial